Arvis Sulovari

Arvis Sulovari

Auto-generated profile, based on publicly available information

Arvis Sulovari

Department of Genome Sciences, University of Washington School of Medicine

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 February 2021 in Science
Verified
Journal Article
Closed access
PDF file
PEPeter Ebert
Peter Ebert
PAPeter A. Audano
Peter A. Audano
QZQihui Zhu
Qihui Zhu
BRBernardo Rodriguez-Martin
Bernardo Rodriguez-Martin
DPDavid Porubsky
David Porubsky
FMF. Kumara Eugene Mastrorosa
F. Kumara Eugene Mastrorosa
Resolving genomic structural variation: Many human genomes have been reported using short-read technology, but it is difficult to resolve structural variants (SVs) using these data. These genomes thus lack comprehensive comparisons among individuals and populations. Ebertet al.used long-read structural variation calling across 64 human genomes representing diverse populations and developed new methods for variant discovery. This approach allowed the authors to increase the number of confirmed SVs and to describe the patterns of variation across populations. From this dataset, they identified quantitative trait loci affected by these SVs and determined how they may affect gene expression and potentially explain genome-wide association study hits. This information provides insights into patterns of normal human genetic variation and generates reference genomes that better represent the diversity of our species.Science, this issue p.eabf7117

1 January 2019 in Cell
Verified
Journal Article
Closed access
PAPeter A. Audano
Peter A. Audano
ASArvis Sulovari
Arvis Sulovari
TGTina A. Graves-Lindsay
Tina A. Graves-Lindsay
SCStuart Cantsilieris
Stuart Cantsilieris
MSMelanie Sorensen
Melanie Sorensen
FMF. Kumara Eugene Mastrorosa
F. Kumara Eugene Mastrorosa

1 April 2022 in Science
Verified
Journal Article
Closed access
MVMitchell R. Vollger
Mitchell R. Vollger
XGXavi Guitart
Xavi Guitart
PDPhilip C. Dishuck
Philip C. Dishuck
LMLudovica Mercuri
Ludovica Mercuri
WHWilliam T. Harvey
William T. Harvey
FMF. Kumara Eugene Mastrorosa
F. Kumara Eugene Mastrorosa
Despite their importance in disease and evolution, highly identical segmental duplications (SDs) are among the last regions of the human reference genome (GRCh38) to be fully sequenced. Using a complete telomere-to-telomere human genome (T2T-CHM13), we present a comprehensive view of human SD organization. SDs account for nearly one-third of the additional sequence, increasing the genome-wide estimate from 5.4 to 7.0% [218 million base pairs (Mbp)]. An analysis of 268 human genomes shows that 91% of the previously unresolved T2T-CHM13 SD sequence (68.3 Mbp) better represents human copy number variation. Comparing long-read assemblies from human ( n = 12) and nonhuman primate ( n = 5) genomes, we systematically reconstruct the evolution and structural haplotype diversity of biomedically relevant and duplicated genes. This analysis reveals patterns of structural heterozygosity and evolutionary differences in SD organization between humans and other primates.

17 December 2018 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
BCBradley P. Coe
Bradley P. Coe
HSHolly A. F. Stessman
Holly A. F. Stessman
ASArvis Sulovari
Arvis Sulovari
MGMadeleine R. Geisheker
Madeleine R. Geisheker
TBTrygve E. Bakken
Trygve E. Bakken
FMF. Kumara Eugene Mastrorosa
F. Kumara Eugene Mastrorosa

1 October 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
TWTianyun Wang
Tianyun Wang
KHKendra Hoekzema
Kendra Hoekzema
DVDavide Vecchio
Davide Vecchio
HWHuidan Wu
Huidan Wu
ASArvis Sulovari
Arvis Sulovari
FMF. Kumara Eugene Mastrorosa
F. Kumara Eugene Mastrorosa
Most genes associated with neurodevelopmental disorders (NDDs) were identified with an excess of de novo mutations (DNMs) but the significance in case–control mutation burden analysis is unestablished. Here, we sequence 63 genes in 16,294 NDD cases and an additional 62 genes in 6,211 NDD cases. By combining these with published data, we assess a total of 125 genes in over 16,000 NDD cases and compare the mutation burden to nonpsychiatric controls from ExAC. We identify 48 genes (25 newly reported) showing significant burden of ultra-rare (MAF < 0.01%) gene-disruptive mutations (FDR 5%), six of which reach family-wise error rate (FWER) significance (p < 1.25E−06). Among these 125 targeted genes, we also reevaluate DNM excess in 17,426 NDD trios with 6,499 new autism trios. We identify 90 genes enriched for DNMs (FDR 5%; e.g., GABRG2 and UIMC1); of which, 61 reach FWER significance (p < 3.64E−07; e.g., CASZ1). In addition to doubling the number of patients for many NDD risk genes, we present phenotype–genotype correlations for seven risk genes (CTCF, HNRNPU, KCNQ3, ZBTB18, TCF12, SPEN, and LEO1) based on this large-scale targeted sequencing effort.

7 December 2020 in Nature Biotechnology
Verified
Journal Article
Open access
PDF file
HCHuman Genome Structural Variation Consortium
Human Genome Structural Variation Consortium
DPDavid Porubsky
David Porubsky
PEPeter Ebert
Peter Ebert
PAPeter A. Audano
Peter A. Audano
MVMitchell R. Vollger
Mitchell R. Vollger
TMTobias Marschall
Tobias Marschall
Human genomes are typically assembled as consensus sequences that lack information on parental haplotypes. Here we describe a reference-free workflow for diploid de novo genome assembly that combines the chromosome-wide phasing and scaffolding capabilities of single-cell strand sequencing1,2 with continuous long-read or high-fidelity3 sequencing data. Employing this strategy, we produced a completely phased de novo genome assembly for each haplotype of an individual of Puerto Rican descent (HG00733) in the absence of parental data. The assemblies are accurate (quality value > 40) and highly contiguous (contig N50 > 23 Mbp) with low switch error rates (0.17%), providing fully phased single-nucleotide variants, indels and structural variants. A comparison of Oxford Nanopore Technologies and Pacific Biosciences phased assemblies identified 154 regions that are preferential sites of contig breaks, irrespective of sequencing technology or phasing algorithms.